Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Lymphoma

Free Subscription 16.01.2012 1 Arch Dermatol 7 Blood 5 Br J Haematol 1 Cancer 1 Cancer Res 1 Hum Pathol 1 Int J Radiat Oncol Biol Phys 1 J Am Acad Dermatol 2 J Clin Oncol 2 Leuk Lymphoma 1 Leukemia 1 Mod Pathol 1 Oncology (Williston Park)

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Arch Dermatol

1. CHAN DV , Staidle J, Tamburro J, Mostow E, et al
   Rapid cutaneous dissemination of persistently agminated lymphomatoid papulosis in a 9-year-old boy.
   Arch Dermatol. 2011;147:1340-2.
   PubMed     Text format     Related articles   
   
   
   

   
   Blood

2. KLAPPER W , Kreuz M, Kohler CW, Burkhardt B, et al
   Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. CARLRING J , Szabo MJ, Dickinson R, De Leenheer E, et al
   Conjugation of lymphoma idiotype to CD40 antibody enhances lymphoma vaccine immunogenicity and anti-tumor effects in mice.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. SABBAH S , Jagne YJ, Zuo J, de Silva T, et al
   T-cell immunity to Kaposi's sarcoma-associated herpesvirus: recognition of primary effusion lymphoma with LANA-specific CD4+ T cells.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. PREGNO P , Chiappella A, Bello M, Botto B, et al
   The interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. LACASCE AS , Vandergrift JL, Rodriguez MA, Abel GA, et al
   Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. GERARD L , Michot JM, Burcheri S, Fieschi C, et al
   Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. WITZIG TE , Tang H, Micallef IN, Ansell SM, et al
   Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas.
   Blood. 2011;118:4882-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Br J Haematol

9. EPSTEIN A
   Burkitt lymphoma and the discovery of Epstein-Barr virus.
   Br J Haematol. 2012 Jan 11. doi: 10.1111/j.1365-2141.2011.09008.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. MITROVIC Z , Bast M, Bierman PJ, Bociek RG, et al
    The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma.
    Br J Haematol. 2012 Jan 9. doi: 10.1111/j.1365-2141.2011.08998.
    PubMed     Text format     Related articles   
    
    
    
11. GREAVES P , Wilson A, Matthews J, Brown DL, et al
    Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a single centre intention-to-treat analysis.
    Br J Haematol. 2012 Jan 9. doi: 10.1111/j.1365-2141.2011.08993.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. WONDERGEM MJ , Zijlstra JM, de Rooij M, Visser OJ, et al
    Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with (90) Yttrium ibritumomab tiuxetan-BEAM and autologous stem cell transplantation.
    Br J Haematol. 2012 Jan 9. doi: 10.1111/j.1365-2141.2011.08991.
    PubMed     Text format     Related articles   
    
    
    
13. WAN MY , Ardeshna KM, Bomanji J
    Neurolymphomatosis in a patient with lymphoblastic lymphoma.
    Br J Haematol. 2012 Jan 6. doi: 10.1111/j.1365-2141.2011.09002.
    PubMed     Text format     Related articles   
    
    
    

    
    Cancer

14. GUIDETTI A , Carlo-Stella C, Ruella M, Miceli R, et al
    Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia.
    Cancer. 2011 May 12. doi: 10.1002/cncr.26182.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Cancer Res

15. GOLDSTEIN MJ , Kohrt HE, Houot R, Varghese B, et al
    Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137 Expressing Regulatory T Cells.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Hum Pathol

16. PAPATHOMAS TG , Venizelos I, Dunphy CH, Said JW, et al
    Mantle cell lymphoma as a component of composite lymphoma: clinicopathologic parameters and biologic implications.
    Hum Pathol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Int J Radiat Oncol Biol Phys

17. HARRISON C , Young J, Navi D, Riaz N, et al
    Revisiting low-dose total skin electron beam therapy in mycosis fungoides.
    Int J Radiat Oncol Biol Phys. 2011;81:e651-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Am Acad Dermatol

18. NOFAL A , Abdel-Mawla MY, Assaf M, Salah E, et al
    Primary cutaneous aggressive epidermotropic CD8(+) T-cell lymphoma: Proposed diagnostic criteria and therapeutic evaluation.
    J Am Acad Dermatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Clin Oncol

19. LIAPIS K , Harhalakis N, Stefanou G, Apostolidis J, et al
    Severe Anemia During Rituximab Maintenance Therapy for Follicular Lymphoma.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles   
    
    
    
20. SIBAI H , Ishak RS, Halawi R, Otrock ZK, et al
    Non-Uremic Calcific Arteriolopathy (Calciphylaxis) in Relapsed/Refractory Hodgkin's Lymphoma: A Previously Unreported Association.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles   
    
    
    

    
    Leuk Lymphoma

21. ITO D , Frantz AM, Williams C, Thomas R, et al
    CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. CHANG JE , Kahl BS
    Bendamustine: more ammunition in the battle against mantle cell lymphoma.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles   
    
    
    

    
    Leukemia

23. BIKOS V , Darzentas N, Hadzidimitriou A, Davis Z, et al
    Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
    Leukemia. 2012 Jan 6. doi: 10.1038/leu.2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Mod Pathol

24. GUALCO G , Natkunam Y, Bacchi CE
    The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases.
    Mod Pathol. 2012 Jan 6. doi: 10.1038/modpathol.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Oncology (Williston Park)

25. YAHALOM J
    Patients with H pylori-independent MALT lymphoma are curable with radiotherapy.
    Oncology (Williston Park). 2011;25:1147-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: